text:
filter your search All ContentAll JournalsJournal of Experimental Medicine
Found in Translation
Article| March 14 2005
Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence
Julianne Stack,
Julianne Stack
1Department of Biochemistry, Trinity College, Dublin 2, Ireland
Ismar R. Haga,
Ismar R. Haga
2Department of Virology, Faculty of Medicine, Imperial College London, St. Mary's Campus, London W2 1PG, England, UK
Martina Schröder,
Martina Schröder
Nathan W. Bartlett,
Nathan W. Bartlett
Geraldine Maloney,
Geraldine Maloney
Patrick C. Reading,
Patrick C. Reading
Katherine A. Fitzgerald,
Katherine A. Fitzgerald
3Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01604
Geoffrey L. Smith,
Geoffrey L. Smith
Andrew G. Bowie
CORRESPONDENCE Andrew Bowie: agbowie@tcd.ie
Abbreviations used: ERK, extracellular signal–regulated kinase; IRAK, IL-1 receptor–associated kinase; IRF3, interferon regulatory factor 3; JNK, c-Jun NH2-terminal protein kinase; Mal, MyD88 adaptor-like; MOI, multiplicity of infection; MyD88, myeloid differentiation factor 88; PAM, pathogen-associated molecule; RANTES, regulated on activation, normal T cell expressed and secreted; SARM, sterile α and HEAT/Armadillo motifs-containing protein; TIR, Toll–IL-1 resistance; TLR, Toll-like receptors; TRAF, TNF receptor–associated factor; TRAM, TRIF-related adaptor molecule; TRIF, TIR domain-containing adaptor inducing IFN-β; VV, vaccinia virus.
J. Stack and I.R. Haga contributed equally to this work.
I.R. Haga's present address is Department of Biochemistry, Trinity College, Dublin 2, Ireland.
P.C. Reading's present address is Department of Microbiology and Immunology, University of Melbourne, Victoria, 3010, Australia.
Received: July 16 2004
Accepted: January 14 2005
The Rockefeller University Press
J Exp Med (2005) 201 (6): 1007–1018.
https://doi.org/10.1084/jem.20041442
Julianne Stack, Ismar R. Haga, Martina Schröder, Nathan W. Bartlett, Geraldine Maloney, Patrick C. Reading, Katherine A. Fitzgerald, Geoffrey L. Smith, Andrew G. Bowie; Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence . J Exp Med 21 March 2005; 201 (6): 1007–1018. doi: https://doi.org/10.1084/jem.20041442
Viral immune evasion strategies target key aspects of the host antiviral response. Recently, it has been recognized that Toll-like receptors (TLRs) have a role in innate defense against viruses. Here, we define the function of the vaccinia virus (VV) protein A46R and show it inhibits intracellular signalling by a range of TLRs. TLR signalling is triggered by homotypic interactions between the Toll-like–interleukin-1 resistance (TIR) domains of the receptors and adaptor molecules. A46R contains a TIR domain and is the only viral TIR domain–containing protein identified to date. We demonstrate that A46R targets the host TIR adaptors myeloid differentiation factor 88 (MyD88), MyD88 adaptor-like, TIR domain–containing adaptor inducing IFN-β (TRIF), and the TRIF-related adaptor molecule and thereby interferes with downstream activation of mitogen-activated protein kinases and nuclear factor κB. TRIF mediates activation of interferon (IFN) regulatory factor 3 (IRF3) and induction of IFN-β by TLR3 and TLR4 and suppresses VV replication in macrophages. Here, A46R disrupted TRIF-induced IRF3 activation and induction of the TRIF-dependent gene regulated on activation, normal T cell expressed and secreted. Furthermore, we show that A46R is functionally distinct from another described VV TLR inhibitor, A52R. Importantly, VV lacking the A46R gene was attenuated in a murine intranasal model, demonstrating the importance of A46R for VV virulence.
The discovery of the Toll-like receptor (TLR) family of proteins has revolutionized the understanding of how the innate immune system recognizes pathogens and initiates an effective and appropriate response (1, 2). TLRs are part of the larger IL-1R/TLR superfamily, which includes IL-1Rs, IL-18Rs, and a group of orphan receptors (3). The family is defined by the presence of a cytoplasmic Toll-like–IL-1 resistance (TIR) domain, which is responsible for mediating downstream signaling. So far, 13 TLRs have been identified; TLRs 1–9 are common to mouse and human, whereas TLR10 is only functional in humans, and TLRs 11, 12, and 13 have been found only in mice (2–5). Many but not all of these receptors have been assigned a role in the initial detection of, and response to, specific pathogen-associated molecules (PAMs). In macrophages and neutrophils, this drives innate immune responses, such as inflammation and induction of microbicidal activity, whereas activation of TLRs expressed on dendritic cells leads to the initiation of adaptive immunity through induction of IL-12 and costimulatory molecules (6, 7).
Although interest focused on the role of TLRs in responding to bacteria initially, there are now three strong lines of evidence that TLRs are also involved in detecting viruses and initiating antiviral responses. First, some TLRs are required for cellular and whole animal responses to certain viruses, viral proteins, and nucleic acids (8, 9). Second, TLRs trigger antiviral signaling pathways leading to the induction of IFN responses (8, 9). Third, viral immune strategies used against TLRs have been identified (8, 9).
Cell surface TLR2 and TLR4 may recognize viral glycoproteins on virions (8, 9). For example, measles virus hemagglutinin activates murine and human cells via TLR2, leading to induction of proinflammatory cytokines and up-regulation of surface expression of CD150, a receptor for measles virus (10). In terms of viral nucleic acids, TLR3 is activated in response to poly(I:C), a synthetic analogue of viral dsRNA (11), whereas TLR7 and TLR8 recognize ssRNA (from influenza, HIV, and vesicular stomatitis virus; references 12–14) and TLR9 responds to dsDNA from herpes simplex virus (15, 16).
That TLR signaling can induce an antiviral state was shown clearly by Doyle et al. (17) in that pretreatment of cells with poly(I:C) or lipid A (the moiety of LPS that is recognized by TLR4) inhibited the replication of a murine herpesvirus in macrophages. Even before the discovery of TLRs, it was known that viral replication and viral pathogenesis often involves NF-κB activation (18). TLRs, like IL-1, mediate downstream signaling mainly through their cytoplasmic TIR domain. This domain mediates homotypic interactions between TLRs, and also recruitment of TIR-containing adaptor proteins, of which myeloid differentiation factor 88 (MyD88) is a prototypical example. Recruitment of MyD88 to TLR complexes leads to activation of IL-1 receptor–associated kinases (IRAKs), which engage with TNF receptor–associated factor (TRAF) 6, leading ultimately to the activation of mitogen-activated protein (MAP) kinases and the transcription factor NF-κB (19, 20). MyD88 is involved in NF-κB activation by every TLR tested thus far, except for TLR3 (21, 22). MyD88 adaptor-like (Mal; reference 23), another TIR adaptor protein, is required specifically for TLR2 and TLR4 signaling (19, 20).
An important MyD88-independent signaling pathway is the activation of the antiviral transcription factor IFN regulatory factor 3 (IRF3) by TLR3 and TLR4. IRF3 activation, together with NF-κB activation, leads to IFN-β induction, which initiates the IFN-based antiviral response. TIR domain-containing adaptor inducing IFN-β (TRIF) is essential for MyD88-independent TLR3 and TLR4 signaling (21, 22, 24). TRIF activates IRF3 via TANK-binding kinase-1 (TBK1), leading to IFN-β expression (25, 26). TRIF probably associates directly with TLR3, but indirectly with TLR4, via a bridging interaction with a fourth adaptor that is unique to the TLR4 signaling pathway, TRIF-related adaptor molecule (TRAM, 27, 28).
Further evidence for the role of TLRs in responding to viruses came from the discovery of viral immune strategies used against TLRs. Vaccinia virus (VV), the poxvirus used to vaccinate against smallpox, encodes proteins that antagonize important components of host antiviral defense. Previously, we showed that VV protein A52R, which has no obvious similarity to host proteins, can block the activation of NF-κB by multiple TLRs, in particular TLR3 (29, 30). A52R associates with both IRAK2 and TRAF6, and disrupts signaling complexes containing these proteins (30). Furthermore, deletion of the A52R gene from VV reduced virus virulence (30).
In contrast with A52R, the VV protein investigated in this work, A46R, has a TIR domain, and as such is the only viral member of the IL-1R/TLR family identified to date (29). Initial studies revealed that A46R could inhibit IL-1, but not TNF-induced NF-κB activation (29). The effect on IL-1, together with the presence of a TIR domain in the protein suggested that A46R may have a role in immune evasion. However, the mechanism of action of A46R, its effect on TLR signaling pathways, and its potential role in virulence were not determined. Here, we show that A46R inhibits TLR-induced signaling, by associating with TIR-domain containing adaptor molecules. This is the first demonstration of direct viral targeting of TIR adaptors. We also demonstrate a role for A46R in VV virulence, and show that A46R and A52R are functionally distinct.
A46R inhibits multiple IL-1–induced signals
Previously, we showed that A46R was capable of suppressing NF-κB activation induced by IL-1, whereas TNF-induced NF-κB was unaffected (29). To further characterize the effects of A46R on cell signaling, first we determined the effect of A46R on other IL-1–dependent signals. The effect of A46R on IL-1–, but not TNF-induced NF-κB–dependent reporter gene activation was confirmed (Fig. 1 a). To measure IL-1–induced transactivation of NF-κB specifically, an assay was performed using an expression plasmid encoding the transactivation domain of the p65 subunit of NF-κB fused to the DNA-binding domain of Gal4, together with a reporter plasmid under the control of a Gal4 upstream activation sequence (31). Reporter gene expression from this plasmid requires p65 transactivation through phosphorylation. Ectopic expression of A46R inhibited IL-1–induced p65 transactivation, but had no effect on basal levels of activity (Fig. 1 b). The effect of A46R on p65 transactivation provided a rationale for the inhibition of the NF-κB–dependent reporter gene. In a similar assay (23), A46R blocked both c-Jun NH2-terminal protein kinase (JNK; Fig. 1 c) and extracellular signal–regulated kinase (ERK; Fig. 1 d) activation induced by IL-1. Thus, A46R inhibited multiple distinct signals emanating from the IL-1 receptor.
A46R interacts with MyD88 and antagonizes MyD88-dependent signaling
The results from Fig. 1 suggest that A46R was acting close to the IL-1 receptor complex. This was also likely given that A46R has a TIR domain (29), as illustrated in Fig. 2 a, which shows an alignment of VV and variola virus A46R with several human TIR-containing proteins. Given that all IL-1 signals tested to date are dependent on the TIR domain-containing adaptor MyD88 (32, 33), including p65 transactivation (31) and JNK activation (34), we reasoned that A46R may target MyD88 via a TIR domain interaction. To test this hypothesis, coimmunoprecipitation studies were performed with A46R and MyD88 expressed ectopically. Fig. 2 b shows a clear interaction between A46R and MyD88 (left). As a control, the ability of A46R to interact with TRAF2, an adaptor used by TNF but not IL-1 (35), was tested in parallel. In this case, no interaction was detected (Fig. 2 a, right), consistent with the lack of effect of A46R on TNF signaling (Fig. 1 a). These results were confirmed by GST-pulldown experiments, whereby purified GST-A46R interacted with ectopically expressed MyD88 in a cell lysate, but not with TRAF2 (Fig. 2 c). A46R also failed to interact with TAB1, a signaling molecule downstream of MyD88 (unpublished data). The interaction of A46R with MyD88 was also demonstrated in cells infected by VV and transfected to express MyD88, to use the A46R protein at its physiological concentration (Fig. 2 d). As a control for specificity, this was compared with a VV deletion mutant lacking the A46R gene (vΔA46R), whereupon no band for A46R was detected (Fig. 2 d). A46R also interacted with MyD88 in a yeast two-hybrid pairwise assay (unpublished data), thus demonstrating that the association was direct.
Apart from its role in IL-1R signaling, MyD88 is also used by murine TLRs 1, 2, 4, 5, 6, 7, and 9 (2). Therefore, we tested the effect of A46R on signaling via these TLRs in RAW264.7 cells, a murine macrophage cell line that expresses most TLRs (36). Stimulation of RAW264.7 cells with MALP-2 (TLR2 and 6), Pam3Cys (TLR2 and 1), LPS (TLR4), flagellin (TLR5), R848 (TLR7), or CpG DNA (TLR9) led to induction of the NF-κB–dependent reporter gene (Fig. 2 e). In each case, the presence of A46R caused strong inhibition of induction, whereas it had no suppressive effect on control levels (Fig. 2 e). Thus, A46R inhibited MyD88-dependent signaling by both IL-1R and TLRs, presumably by interacting with MyD88 via its TIR domain.
A46R targets the TLR4 receptor complex
The effect of A46R on TLR4 signaling was examined in greater detail. A chimeric form of TLR4, comprising the murine CD4 extracellular domain fused to the cytoplasmic domain of human TLR4, which renders TLR4 constitutively active (37), was used. Overexpression of CD4-TLR4 induced NF-κB, and this was inhibited by coexpression of A46R in a dose-dependent manner (Fig. 3 a, left). In fact, the highest concentration of A46R-expressing plasmid almost completely prevented TLR4-induced NF-κB activation, whereas it did not suppress basal levels of reporter gene activity (Fig. 3 a, left, white bars). TLR4-induced activation of the MAP kinases p38 and ERK was also inhibited by A46R expression (Fig. 3, middle and right, respectively).
Given that TLR4-induced NF-κB, p38, and ERK are only partially MyD88 dependent (38), it was difficult to account for the potent effects of A46R on these signals by an interaction with MyD88 alone. Therefore, we assessed the ability of A46R to target other TIR domain-containing proteins involved in the TLR4 receptor complex. Fig. 3 b shows that A46R could be immunoprecipitated with TLR4 itself, suggesting that A46R can also interact with the TLR4 TIR domain. Next, we tested the ability of A46R to target two important TLR4 TIR adaptors, Mal and TRAM. Mal and TRAM are thought to interact directly with TLR4, and subsequently recruit MyD88 and TRIF, respectively (23, 27, 39). Both Mal and TRAM are essential for robust TLR4-dependent NF-κB activation (19, 23, 27, 28). Consistent with this, A46R immunoprecipitated with both Mal (Fig. 3 c) and TRAM (Fig. 3 d). The interactions with TLR4, Mal, and TRAM were confirmed by GST-pulldown experiments (Fig. 3 e). Furthermore, Mal was shown to coimmunoprecipitate with A46R in infected cells, associate directly with A46R in the yeast two-hybrid pairwise assay, and rMal interacted with GST-A46R in vitro (unpublished data).
Next, we demonstrated that the inhibitory effects of A46R on TLR4 signaling pathways also resulted in a suppression of gene induction. Fig. 3 f shows that LPS stimulation of HEK293 cells expressing TLR4 led to the release of IL-8, which is NF-κB and p38 dependent (not depicted). Transient transfection of these cells with A46R suppressed IL-8 release by ∼50%. Thus, the viral TIR domain of A46R can target multiple human TIR domain-containing proteins important for TLR4 signaling, leading to antagonism of signaling pathways and subsequent suppression of gene induction.
A46R antagonizes TRIF-dependent pathways
TRIF was identified as a TIR adaptor molecule capable of directing both TLR4- and TLR3-induced IRF3 activation, leading to IFN-β induction, which is independent of MyD88 (21, 22, 24). The MyD88-independent late activation of NF-κB by TLR4 was also explained by the discovery of TRIF (21). Given the central role of TRIF in the activation of the antiviral transcription factor IRF3, we wondered whether A46R would also target this TIR adaptor directly. Co-expression of A46R and TRIF, with subsequent coimmunoprecipitation, demonstrated that these two proteins could indeed form a complex (Fig. 4 a). An interaction between A46R and TRIF was confirmed by a GST-pulldown experiment (Fig. 4 b) and also by a yeast two-hybrid pairwise assay (not depicted).
To determine the functional relevance of this interaction, the effect of A46R on TRIF-dependent signals was examined. For this, IRF3 activation by TLR4 and TLR3 was assessed by using a Gal4–IRF3 fusion protein together with a Gal4-dependent reporter plasmid, which requires IRF3 transactivation to express the reporter gene (27). Ectopic expression of CD4-TLR4 resulted in a threefold induction of this IRF3-dependent reporter, and this was completely blocked by coexpression of A46R (Fig. 4 c, top). Although the interaction of A46R with TLR4 and TRAM probably contributes to this inhibitory effect, induction of an IFN-β promoter reporter gene by ectopic expression of TRIF was also blocked by A46R (unpublished data), suggesting a direct effect on TRIF, which is downstream of TLR4 and TRAM. Further TLR3-dependent activation of IRF3 by poly(I:C), which is entirely TRIF dependent, was also completely blocked by A46R (Fig. 4 c, bottom). A46R also inhibited LPS and poly(I:C)-mediated induction of an ISRE-dependent reporter (unpublished data). In addition, no interaction between A46R and TLR3 was detected (unpublished data). Furthermore, poly(I:C)-induced regulated on activation, normal T cell expressed and secreted (RANTES) release from HEK293 cells stably expressing TLR3 was inhibited by A46R (Fig. 4 d). This represents inhibition of gene induction that is entirely independent of MyD88 (27). Therefore, A46R blocks TLR-induced IRF3 activation and subsequent gene induction by directly targeting TRIF.
Thus, A46R was capable of interacting with four TIR adaptors known to have a key role in IL-1R and TLR-induced signaling. In contrast, A46R did not interact with the fifth human intracellular TIR domain-containing protein, sterile α and HEAT/Armadillo motifs–containing protein (SARM) in a coimmunoprecipitation (Fig. 4 e) or GST-pulldown (Fig. 2 f) assay. This is consistent with the fact that SARM does not lead to NF-κB or IRF3 activation (40), and provided an important specificity control for A46R interactions.
A46R is expressed early during infection and contributes to VV virulence
To determine when A46R was expressed during the virus life cycle, cells were infected for different lengths of time in the presence or absence of cytosine β-D-arabinofuranoside (AraC) (an inhibitor of virus DNA replication and, therefore, of intermediate and late genes) and analyzed by immunoblotting. Fig. 5 a (top) shows that A46R expression was detected in the presence of AraC, whereas a late protein (D8L) was not (Fig. 5 a, bottom), showing early expression. A46R remained in infected cells up to 24 h after infection.
To explore the role of A46R in VV virulence, a VV deletion mutant lacking the A46R gene was constructed (vΔA46R). As a control, a revertant virus was also constructed in which the A46R gene was reinserted into the vΔA46R mutant (vA46R-REV). Western blot analysis confirmed expression of A46R in wild-type virus (vWT-A46R) and vA46R-REV, but not in vΔA46R (Fig. 2 d and not depicted). Mice were infected intranasally with vΔA46R, vA46R-REV, or vWT-A46R and were weighed and assessed for signs of illness daily. Fig. 5 b shows that vΔA46R was attenuated relative to both vWT-A46R and vA46R-REV in terms of reduced weight loss (Fig. 5 b, top graph) and milder signs of illness (bottom graph). Assessment of the total number of cells in lungs after infection revealed a difference in the kinetics of the host response to vΔA46R compared with vA46R-REV or vWT-A46R, in that when the virus lacked A46R, the number of cells present on day two was increased, whereas on days 5 and 8, it was reduced. The difference in cell recruitment between the vWT-A46R and vΔA46R on day 5 was statistically significant (P < 0.05). The p-value for the difference between vWT-A46R and vΔA46R on day 8 was 0.09, whereas the value for the difference between vA46R-REV and vΔA46R was 0.04.
A46R and A52R are not functionally redundant
Previously, we showed that the poxviral protein A52R could also inhibit TLR signaling and contribute to virulence (30). A52R does not resemble any host proteins, but does have some similarity to A46R (29, 30). A52R blocked TLR-induced NF-κB activation by targeting TRAF6 and IRAK2, which act downstream of TIR adaptors (30). Therefore, we looked in more detail at the effects of both proteins on signaling by a single TLR, to ascertain whether or not they were functionally redundant. We chose TLR3, given its proposed role in the antiviral response, and also because it signals via a single TIR adaptor, TRIF, thus making the interpretation of the results more definitive. Analysis of NF-κB and IRF3 activation by TLR3 demonstrated a clear difference between A46R and A52R. Fig. 6 a shows that A52R was a potent inhibitor of poly(I:C)/TLR3-induced NF-κB activation, whereas A46R had little effect. In contrast, Fig. 6 b shows that IRF3 activation induced by poly(I:C)/TLR3 was sensitive to A46R, but not A52R. Furthermore, A52R was not capable of inhibiting IL-1 or TLR4-induced MAP kinase activation (not depicted), which were clearly blocked by A46R (Fig. 1, c and d, and Fig. 3, a and b). Hence, A46R and A52R are not functionally redundant in that both are required to effectively shut down TLR3 signaling, whereas only A46R is capable of inhibiting TLR-induced MAP kinase activation.
The results demonstrate that A46R has a viral TIR domain with which it targets TIR adaptor molecules, resulting in inhibition of both MyD88-dependent and TRIF-dependent signaling and gene induction. Furthermore, A46R is functionally distinct from A52R and contributes to VV virulence, most likely due to its inhibitory effects on TIR-dependent signaling.
The identification of viral immune evasive strategies and the analysis of the molecular aspects of host–pathogen interactions are crucial to enhancing understanding of microbial pathogenesis and immunity to infection. Given the emerging importance of the TLR system in the antiviral response, understanding how viruses target this receptor family is of particular interest. During a database search for novel TIR domain–containing proteins, A46R from VV was identified (29). This was potentially interesting because many poxviral immunomodulatory proteins, such as cytokine-binding proteins, bear sequence similarity to host factors (41). To date, A46R is the only identified viral TIR domain–containing protein. In this paper, we show that A46R is an intracellular inhibitor of multiple TLR-dependent signaling pathways, define host signaling molecules that it targets, and demonstrate that the protein contributes to VV virulence in vivo.
The observation that A46R blocked all IL-1 signals tested (NF-κB, JNK, and ERK activation) suggested that it was acting close to the IL-1R complex. Furthermore, the presence of a TIR domain within A46R, the knowledge that TIR domains participate in homotypic interactions, and the fact that all the signals blocked by A46R were MyD88 dependent (31–34), suggested that MyD88 may be sequestered by A46R. Coimmunoprecipitation and GST-pulldown experiments demonstrated an interaction between A46R and MyD88. This also suggested that A46R would antagonize TLR signaling, given the central role of MyD88 in many of these pathways. In fact, A46R inhibited every murine TLR pathway to NF-κB activation known to involve MyD88 in a mouse macrophage cell line, together with TLR4-mediated NF-κB, p38, and ERK activation, and IL-8 induction in human 293 cells.
Inhibition of TLR4-dependent NF-κB signaling in human cells was particularly potent, which led us to test the effect of A46R on other TIR domain–containing proteins with a role in this pathway. Altogether, five such proteins are known to be involved in TLR4-mediated NF-κB activation, namely the receptor itself, MyD88, Mal, TRAM, and TRIF (19–23, 28). A46R was found to be capable of associating with all five of these proteins, and hence it probably prevents the formation of the TLR4 receptor complex, thus accounting for its potent inhibition of NF-κB activation. Although these results were based on overexpression, several lines of evidence suggest that the interactions detected are specific, direct, and likely to occur in vivo. First, normally VV-expressed A46R interacted with MyD88 and Mal. Second, the interaction of A46R with MyD88, Mal, and TRIF were confirmed in yeast two-hybrid. Third, rMal interacted directly with GST-A46R in vitro. Finally, A46R displayed specificity for certain TIR domain–containing proteins and did not interact with TLR3 or SARM.
A46R is the first viral protein identified that can target host TIR domain–containing proteins. Given its ability to interact with different and diverse TIR domains (TRIF and TRAM are quite distinct in sequence from MyD88 and Mal; Fig. 1 a and reference 20), elucidation of the crystal structure of A46R should provide important information of general relevance as to how TIR domains interact. Because Box 2 of the TIR domain is particularly important in signaling (42), the extra amino acids surrounding the A46R Box 2 (Fig. 1 a) may represent inhibitory loops that account for the ability of A46R to prevent TIR-dependent signaling. This hypothesis is being explored using mutagenesis studies.
The fact that A46R associated with all four TLR4 adaptors may suggest that TLR4 is a particularly important target for VV immune evasion. Indeed, TLR4 has been proposed to have a role in responding to fusion (F) protein of respiratory syncytial virus (43), although the functional significance of this remains to be clarified (44). TLR4 is also activated by envelope proteins from both mouse mammary tumor virus and Moloney murine leukemia virus, which could also be coimmunoprecipitated with TLR4 (45). VV might interact with other or multiple TLRs that also use these adaptors. Possible VV PAMs detected by TLRs could be proteins on the surface of the intracellular mature virus or extracellular enveloped virus particles (potentially detected by TLR2 or TLR4; references 8, 9), intracellular dsRNA produced from the bidirection transcription of the VV genome (potentially detected by TLR3; reference 11), or the dsDNA genome itself (potentially detected by TLR9, which responds to the dsDNA genome of herpes simplex virus; reference 15, 16). The role of TLRs in responding to VV PAMs is currently being investigated.
Although Mal and TRAM are yet to be directly implicated in responding to viruses, MyD88 (for TLR7; references 8, 9) and TRIF (for TLR3) have been shown to have a role, particularly in relation to type I IFN production (15, 16, 21, 22). TRIF is essential for both TLR4- and TLR3-mediated IRF3 activation and IFN-β production (21, 22) and probably has a key role in the initiation of the IFN-based antiviral response, leading to the inhibition of viral replication and spread. Although the relevance of TLR3 in responding to viruses in vivo has recently been questioned (46, 47), there is evidence that TRIF is important in controlling VV replication. Hoebe et al. (22) showed that macrophages from mice in which trif was disrupted supported the replication of VV to a higher titre than did macrophages from normal mice. Thus, the ability of A46R to inhibit TRIF-mediated IRF3 activation may be of primary importance to VV infection.
Consistent with its proposed role in antagonizing early innate TLR responses, A46R was expressed early during infection. Furthermore, deletion of A46R from VV caused attenuation in a murine intranasal model, and also led to enhanced levels of cells on day 2 in lungs of infected animals. The use of a revertant virus in which the A46R gene was reinserted into the deletion virus confirmed that the attenuation observed in the deletion virus, and the difference in lung cell numbers, were due solely to the absence of A46R. The ability of A46R to target intracellular TIR-dependent signaling most likely accounts for its role in virulence, probably by blocking the induction of immune response genes downstream of TLRs, as has been shown here for the chemokines IL-8 and RANTES. Possibly, inhibition of chemokine induction by A46R might account for the early enhanced levels of cells in the absence of A46R expression.
Previously, we identified another VV TLR antagonist, A52R, which could inhibit TLR-dependent NF-κB activation. There are several lines of evidence that A46R and A52R are not functionally redundant. First, they target distinct TLR signaling molecules (30). Second, although they do have some overlapping effects (such as the inhibition of MyD88-dependent NF-κB activation), their overall effects on TLR signaling are quite distinct. Although A52R is a good NF-κB inhibitor, it has no inhibitory effect on MAP kinase activation (not depicted), nor on TLR3-mediated IRF3 activation (Fig. 6 b). In contrast, A46R blocks both MAP kinase activation and, importantly, TLR3- and TRIF-mediated IRF3 activation. Furthermore, A46R has little effect on TLR3-mediated NF-κB activation, which A52R blocks potently (Fig. 6 a). This was surprising because A46R interacts with TRIF. But, presumably, the interaction of A46R with TRIF has a greater effect on downstream IRF3 activation compared with NF-κB because these two pathways bifurcating from TRIF have been shown to be quite distinct (48, 49). Finally and crucially, the deletion of either A46R or A52R from VV causes attenuation (Fig. 5 b and reference 30) and, thus, both contribute to virulence and are nonredundant.
N1L is another intracellular VV protein that contributes to virulence (50), which has also been shown recently to function by antagonizing TLR signaling, but at the level of IκB kinases and related kinases involved in IRF3 activation (51). Thus, the importance of blocking TLR signaling is demonstrated by the retention by VV of at least three distinct mechanisms of disrupting these pathways. Furthermore, the attenuated phenotypes seen in the absence of A46R, A52R, or N1L provide evidence for a role for TLRs in containing VV infections. The action of these intracellular TLR inhibitory proteins would be expected to be restricted to infected cells, whereas immunomodulatory proteins secreted from VV-infected cells, such as cytokine, chemokine, and IFN-binding proteins, can act on ligands produced from both infected and uninfected cells.
Finally, A46R is also found in variola virus, the causative agent of smallpox. Concern about the threat of the use of variola as a bioweapon has led to a renewed desire to understand this human pathogen. However, little is known about the role of human TLRs in sensing variola virus. Given that VV A46R targets human adaptors, the knowledge that A52R is truncated in variola virus, together with the fact that the VV and variola virus A46R amino acid sequences differ by only eight residues (Fig. 2 a), it is likely that variola virus A46R would have an important role in interactions with the human TLR system.
Expression plasmids
Sources of expression plasmids were as follows: AU1-MyD88 and Flag-TLR4 (M. Muzio, Mario Negri Institute, Milan, Italy; references 52, 53), flag-TRAF2 (Tularik Inc.), chimeric receptor CD4-TLR4 (R. Medzhitov, Yale University, New Haven, CT), TLR3 (D. Golenbock, University of Massachusetts Medical School, Worcester, MA), Flag-TRIF (S. Akira, Osaka University, Osaka, Japan), and Myc-MyD88 (L. O'Neill, Trinity College, Dublin, Ireland). Construction of A46R, Flag-A46R, HA-Mal, Flag-TRAM, and Flag-SARM were described previously (23, 27, 29, 40). The glutathione S-transferase (GST) fusion of A46R was synthesized by inserting full-length A46R in the bacterial expression vector GEX4T2.
Antibodies and reagents
Anti-A46R polyclonal Ab was raised against a purified, bacterial-expressed A46R–GST fusion protein. Other antibodies used were anti-Flag M2 mAb, anti-Flag M2–conjugated agarose, anti-myc mAb clone 9E10 (all obtained from Sigma-Aldrich), anti-AU1 mAb (BabCO), anti-HA polyclonal Ab (Y-11), anti-TRAF2 Ab (both obtained from Santa Cruz Biotechnology, Inc.), and anti-D8L mAb (54).
Human rIL-1α was a gift from the National Cancer Institute and human rTNF-α was a gift from S. Foster (Zeneca Pharmaceuticals, Macclesfield, England). TLR agonists used were poly(I:C) (Amersham Biosciences), LPS (Sigma-Aldrich), R-848 (a gift from D. Golenbock, University of Massachusetts Medical School, Worcester, MA), flagellin (a gift from A. Gewirtz, Emory University, Atlanta, GA), phosphothioate CpG DNA (Sigma-Aldrich), synthetic tripalmitoyl lipopeptide Pam3Cys-Ser-(Lys)4 (Pam3Cys; Invivogen), and macrophage-activating lipopeptide 2 kD (MALP-2; Qbiogene).
Reporter gene assays
HEK 293 cells (2 × 104 cells per well) or RAW264.7 cells (4 × 104 cells per well) were seeded into 96-well plates and transfected 24 h later with expression vectors and luciferase reporter genes using GeneJuice (Novagen). In all cases, 20 ng/well of phRL-TK reporter gene (Promega) was cotransfected to normalize data for transfection efficiency. The total amount of DNA per transfection was kept constant at 220 ng (HEK293) or 200 ng (RAW264.7) by addition of pcDNA3.1 (Stratagene). After 24 h, reporter gene activity was measured (30). Data are expressed as the mean fold induction ± SD relative to control levels, for a representative experiment from a minimum of three separate experiments, each performed in triplicate.
For NF-κB assays, 60 ng of a κB-luciferase reporter gene was used (30). For MAP kinase reporter assays, the Pathdetect System (Stratagene) was used, whereby 0.25 ng c-jun–, 2 ng Elk1–, or 0.25 ng CHOP–Gal4 fusion vectors were used in combination with 60 ng pFR-luciferase reporter to measure JNK, ERK1/2, and p38 activation, respectively. For the p65 transactivation assay, 1 ng of a p65 Gal4 fusion vector was used in combination with 60 ng pFR-luciferase reporter (31). For the IRF3 assay, an IRF3-Gal4 fusion vector (3 ng) was used in combination with 60 ng pFR luciferase reporter (27).
Immunoprecipitation and immunoblotting
HEK293 cells were seeded into 10-cm dishes (1.5 × 106 cells) 24 h before transfection with GeneJuice. For coimmunoprecipitations, 4 μg of each construct was transfected. Cells were harvested after 24 h in 850 μl of lysis buffer (50 mM Hepes, pH 7.5, 100 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40 containing 0.01% aprotinin, 1 mM sodium orthovanadate, and 1 mM PMSF). For assessment of the A46R–TLR4 interaction, the cells were harvested after 48 h and lysed for 1 h in a different lysis buffer (50 mM Tris/HCl, pH 7.5, 1 mM EDTA, 10% glycerol, 0.05% CHAPS. 0.5% Triton X-100, 250 mM NaCl containing 0.01% aprotinin, 1 mM sodium orthovanadate, and 1 mM PMSF). For assessment of interactions involving VV-expressed A46R, cells were infected (multiplicity of infection [MOI] = 1) with VV Western Reserve 24 h after transfection for 90 min at 37°C. The virus inoculum was aspirated and cell monolayers were overlaid with 2.5% FBS DMEM and harvested 24 h after infection in lysis buffer. For all immunoprecipitations, the appropriate antibodies were precoupled to either protein A or protein G–Sepharose for 1 h at 4°C before incubation with the cell lysates overnight at 4°C. The immune complexes were precipitated, washed, and analyzed by SDS-PAGE and immunoblotting (30).
For analysis of the kinetics of A46R expression, confluent monolayers of BSC-1 cells were infected (MOI = 5) for 90 min at 37°C. After removal of inoculum, cell monolayers were overlaid with 2.5% FBS DMEM in the presence or absence of 40 μg/ml cytosine β-D-arabinofuranoside (Sigma-Aldrich). Cell lysates were analyzed by immunoblotting using anti-A46R or anti-D8L Ab.
GST pulldown assays
Plasmid GEX.4T2-A46R or GEX.4T2 was transformed into Escherichia coli BL21 (DE3) and grown in Terrific Broth. Protein expression was induced with 0.7 mM IPTG. Cells were lysed in NETN and proteins were purified from the insoluble fraction by glutathione sepharose 4B affinity chromatography (Amersham Biosciences).
For GST pulldown experiments, HEK 293T cells were transfected and harvested as described for coimmunoprecipitation. 800 μl of cell lysate was added to purified GST-fusion protein coupled to glutathione-sepharose and incubated for 2 h at 4°C. The immune complexes were precipitated, subjected to SDS-PAGE, and were analyzed by immunoblotting.
Determination of cytokine concentrations
HEK293 clonal cell lines expressing either TLR3 (HEK-TLR3) or TLR4 and MD-2 (HEK-TLR4; reference 27) and were used for determination of cytokine production. Cells (2 × 104 cells per well) transfected with the A46R expression plasmid for 24 h were stimulated with 1 μg/ml LPS or 25 μg/ml poly(I:C) 24 h later. Supernatants were harvested 24 h later and IL-8 and RANTES concentrations were determined by ELISA (R&D Systems). Experiments were performed four times in triplicate and data are expressed as the mean ± SD from one representative experiment.
Recombinant VV viruses
A VV mutant (strain WR) lacking 93.5% of the A46R gene (vΔA46R) was constructed by transient dominant selection (55). A plaque-purified wild-type virus (vWT-A46R) and a revertant virus (vA46R-REV) in which the A46R gene was reinserted at its natural locus were also isolated. The virulence of the viruses was investigated in a mouse intranasal model. Female, 6-wk-old BALB/c mice were anesthetized and inoculated with 5 × 103 plaque-forming units of VV in 20 μl of phosphate-buffered saline. A control group was mock-infected with phosphate-buffered saline. Each day, the weights of the animals and signs of illness were measured as described previously (56). On days 2, 5, and 8, single cell suspensions of lung cells were prepared by sieving lungs through a 100-μm nylon mesh followed by hypotonic lysis of erythrocytes. Cell viability was assessed using trypan blue exclusion. Statistical significance was assessed using Student's t test. The animal experiments were conducted under the appropriate licence and regulations stipulated by the Animals (Scientific Procedures) Act 1986, UK government.
Alignment of TIR domains
TIR domains from human proteins with assigned functions were aligned with VV and variola virus A46R using Clustal W. The alignment was viewed and adjusted using GeneDoc (57).
This work was supported by the Irish Higher Education Authority, Enterprise Ireland, The Irish Health Research Board, and Science Foundation Ireland. G.L. Smith is a Wellcome Trust Principal Research Fellow. I.R. Haga was a CNPq (Brazil) scholar. K.A. Fitzgerald is supported by a fellowship from the Wellcome Trust, London.
The authors have no conflicting financial interests.
Janeway, C.A. Jr., and R. Medzhitov.
. Innate immune recognition.
Annu. Rev. Immunol.
Takeda, K., T. Kaisho, and S. Akira.
. Toll-like receptors.
Dunne, A., and L.A.J. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE. 2003:re3.
Zhang, D., G. Zhang, M.S. Hayden, M.B. Greenblatt, C. Bussey, R.A. Flavell, and S. Ghosh.
. A toll-like receptor that prevents infection by uropathogenic bacteria.
Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al.
. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
Proc. Natl. Acad. Sci. USA.
Reis e Sousa, C.
. Toll-like receptors and dendritic cells: for whom the bell tolls.
Semin. Immunol.
Pasare, C., and R. Medzhitov.
. Toll-like receptors and acquired immunity.
Vaidya, S.A., and G. Cheng.
. Toll-like receptors and innate antiviral responses.
Curr. Opin. Immunol.
Rassa, J.C., and S.R. Ross.
. Viruses and Toll-like receptors.
Microbes Infect.
Bieback, K., E. Lien, I.M. Klagge, E. Avota, J. Schneider-Schaulies, W.P. Duprex, H. Wagner, C.J. Kirschning, V. Ter Meulen, and S. Schneider-Schaulies.
. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling.
J. Virol.
Alexopoulou, L., A. Czopik-Holt, R. Medzhitov, and R. Flavell.
. Recognition of double stranded RNA and activation of NF-κB by Toll-like receptor 3.
Diebold, S.S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa.
. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.
Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer.
. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.
Lund, J.M., L. Alexopoulou, A. Sato, M. Karow, N.C. Adams, N.W. Gale, A. Iwasaki, and R.A. Flavell.
. Recognition of single-stranded RNA viruses by Toll-like receptor 7.
Krug, A., G.D. Luker, W. Barchet, D.A. Leib, S. Akira, and M. Colonna.
. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.
Blood.
Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki.
. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells.
J. Exp. Med.
Doyle, S.E., S.A. Vaidya, R. O'Connell, H. Dadgostar, P.W. Dempsey, T.-T. Wu, G. Rao, R. Sun, M.E. Haberland, R.L. Modlin, and G. Cheng.
. IRF3 mediates a TLR3/TLR4-specific antiviral gene program.
Immunity.
Hiscott, J., H. Kwon, and P. Genin.
. Hostile takeovers: viral appropriation of the NFκB pathway.
J. Clin. Invest.
Yamamoto, M., K. Takeda, and S. Akira.
. TIR domain-containing adaptors define the specificity of TLR signalling.
Mol. Immunol.
O'Neill, L.A.J., K. Fitzgerald, and A.G. Bowie.
. The Toll-IL-1 receptor adaptor family grows to five members.
Trends Immunol.
Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira.
. Role of adaptor TRIF in the MyD88-independent toll-like receptor signalling pathway.
Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S.O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, et al.
. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
Fitzgerald, K.A., E.M. Palsson-McDermott, A.G. Bowie, C.A. Jefferies, A.S. Mansell, G. Brady, E. Brint, A. Dunne, P. Gray, M.T. Harte, et al.
. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira.
. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
J. Immunol.
Fitzgerald, K.A., S.M. McWhirter, K.L. Faia, D.C. Rowe, E. Latz, D.T. Golenbock, A.J. Coyle, S.M. Liao, and T. Maniatis.
. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
Nat. Immunol.
McWhirter, S.M., K.A. Fitzgerald, J. Rosains, D.C. Rowe, D.T. Golenbock, and T. Maniatis.
. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts.
Fitzgerald, K.A., D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Visintin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock.
. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira.
. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signalling pathway.
Bowie, A., E. Kiss-Toth, J.A. Symons, G.L. Smith, S.K. Dower, and L.A.J. O'Neill.
. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling.
Harte, M.T., I.R. Haga, G. Maloney, P. Gray, P.C. Reading, N.W. Bartlett, G.L. Smith, A. Bowie, and L.A.J. O'Neill.
. The poxvirus protein A52R targets Toll-like receptor signalling complexes to suppress host defence.
Jefferies, C., A. Bowie, G. Brady, X. Li, and L.A.J. O'Neill.
. Transactivation by the p65 Subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1.
Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira.
. Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function.
Burns, K., F. Martinon, C. Esslinger, H. Pahl, P. Schneider, J.-L. Bodmer, F. Di Marco, L. French, and J. Tschopp.
. MyD88, an adapter protein involved in interleukin-1 signaling.
Janssens, S., and R. Beyaert.
. A universal role for MyD88 in TLR/IL-1R-mediated signaling.
Trends Biochem. Sci.
Hsu, H., H.-B. Shu, M.-G. Pan, and D.V. Goeddel.
. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
Applequist, S.E., R.P.A. Wallin, and H.-G. Ljunggren.
. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines.
Int. Immunol.
Medzhitov, R., P. Preston-Hurlburt, and C.A. Janeway.
. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira.
. Unresponsiveness of MyD88-deficient mice to endotoxin.
Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya.
. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction.
Liberati, N.T., K.A. Fitzgerald, D.H. Kim, R. Feinbaum, D.T. Golenbock, and F.M. Ausubel.
. Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response.
Alcami, A., and U.H. Koszinowski.
. Viral mechanisms of immune evasion.
Immunol. Today.
Xu, Y., X. Tao, B. Shen, T. Horng, R. Medzhitov, J.L. Manley, and L. Tong.
. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
Kurt-Jones, E.A., L. Popova, L. Kwinn, L.M. Haynes, L.P. Jones, R.A. Tripp, E.E. Walsh, M.W. Freeman, D.T. Golenbock, L.J. Anderson, and R.W. Finberg.
. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.
Ehl, S., R. Bischoff, T. Ostler, S. Vallbracht, J. Schulte-Monting, A. Poltorak, and M. Freudenberg.
. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus.
Eur. J. Immunol.
Rassa, J.C., J.L. Meyers, Y. Zhang, R. Kudaravalli, and S.R. Ross.
. Murine retroviruses activate B cells via interaction with toll-like receptor 4.
Edelmann, K.H., S. Richardson-Burns, L. Alexopoulou, K.L. Tyler, R.A. Flavell, and M.B.A. Oldstone.
. Does Toll-like receptor 3 play a biological role in virus infections?
Virology.
Levy, D.E., and I.J. Marié.
. RIGging an antiviral defense–it's in the CARDs.
Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira.
. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Meylan, E., K. Burns, K. Hofmann, V. Blancheteau, F. Martinon, M. Kelliher, and J. Tschopp.
. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation.
Bartlett, N., J.A. Symons, D.C. Tscharke, and G.L. Smith.
. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence.
J. Gen. Virol.
DiPerna, G., J. Stack, A.G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K.A. Fitzgerald, and W.L. Marshall.
. Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors.
Muzio, M., J. Ni, P. Feng, and V.M. Dixit.
. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.
Muzio, M., G. Natoli, S. Saccani, M. Levrero, and A. Mantovani.
. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6).
Parkinson, J.E., and G.L. Smith.
. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
Falkner, F.G., and B. Moss.
. Transient dominant selection of recombinant vaccinia viruses.
Alcami, A., and G.L. Smith.
. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.
Cell.
Nicholas, K.B., H.B. Nicholas Jr., and D.W. Deerfield II.
. GeneDoc: analysis and visualization of genetic variation.
EMBNEW. News.
View large Download slide
A46R inhibits multiple IL-1–dependent signals. HEK 293 cells were transfected with 100 ng A46R or pcDNA3.1 (EV) and the NF-κB (a), p65 (b), JNK (c), or ERK (d) reporter plasmids as described in Materials and methods. 6 h before harvesting, the cells were stimulated with either 100 ng/ml IL-1 or 100 ng/ml TNF as indicated, and luciferase reporter gene activity was measured.
A46R associates with MyD88 and blocks MyD88-dependent signaling. (a) Alignment of A46R with human TIR domains. The conserved motifs Box 1, Box 2, and Box 3 are indicated by a solid line. The eight differences between VV and variola virus A46R sequences are indicated by an asterisk. For A46R, amino acids 35–238 are shown. (b) HEK 293T cells were transfected with A46R and AU1-MyD88 (left) or Flag-TRAF2 (right) as indicated. After 24 h, lysates were subject to immunoprecipitation, SDS-PAGE, and immunoblotting with the indicated antibodies. (c) HEK 293T cells were transfected with 8 μg AU1-MyD88 (top) or Flag-TRAF2 (bottom). After 24 h, lysates were incubated with GST alone (lane 2) or GST-A46R (lane 3), and together with whole cell lysates (lane 1) were analyzed by SDS-PAGE and immunoblotting with the indicated antibodies. (d) HEK 293 cells were transfected with 4 μg of myc-MyD88. After 24 h, cells were infected with viruses either containing (vWT-A46R) or not (vΔA46R) the A46R gene (MOI = 1) and harvested 24 h after infection. Lysates were subjected to immunoprecipitation, SDS-PAGE, and immunoblotting with the indicated antibodies. Whole cell lysates were analyzed for expression of A46R. (e) Murine macrophage RAW 264.7 cells were transfected with the phRL-TK reporter gene and the NF-κB luciferase construct as described in Materials and methods, together with pcDNA3.1 or 100 ng A46R. Cells were stimulated for 6 h with 10 nM MALP-2 (MALP), 5 μg/ml Pam3Cys (Pam), 1 μg/ml LPS, 250 ng/ml Flagellin (Flag), 1 μM R-848, or 5 μg/ml CpG DNA. Cells were harvested 24 h after transfection and the reporter gene activity was measured.
A46R inhibits TLR4 signaling and interacts with TLR4, Mal, and TRAM. (a) HEK 293 cells were transfected with 50 ng CD4-TLR4, 25–100 ng A46R, or pcDNA3.1 (EV) and the NF-κB (left), p38 (middle), or ERK (right) reporter plasmids as indicated. Cells were harvested 24 h after transfection, and luciferase reporter gene activity was measured. (b–d) HEK 293T cells were transfected with A46R and Flag-TLR4 (b), Flag-Mal (c), or Flag-TRAM (d) as indicated. After 24 h, lysates were subject to immunoprecipitation, SDS-PAGE, and immunoblotting with the indicated antibodies. (e) HEK 293T cells were transfected with 8 μg of Flag-TLR4 (top), Flag-Mal (middle), or Flag-TRAM (bottom). After 24 h, lysates were incubated with GST-A46R (lane 3) or GST alone (lane 2), and together with whole cell lysate (lane 1), were analyzed by SDS-PAGE and immunoblotting with the indicated antibodies. (f) HEK-TLR4 cells were transfected with the indicated amounts (ng) of A46R 24 h before stimulation with 1 μg/ml LPS, and 24 h after stimulation, supernatants were harvested and assayed for IL-8 by ELISA.
A46R associates with TRIF and inhibits TRIF-dependent signaling and gene induction. (a) HEK 293T cells were transfected with A46R and Flag-TRIF as indicated. After 24 h, lysates were subject to immunoprecipitation, SDS-PAGE, and immunoblotting with the indicated antibodies. (b) HEK 293T cells were transfected with 8 μg Flag-TRIF. After 24 h, lysates were incubated with GST-A46R (lane 3) or GST alone (lane 2), and together with whole cell lysates (lane 1), were analyzed by SDS-PAGE and immunoblotting with anti-Flag Ab. (c) HEK 293 cells were transfected with the IRF3 reporter plasmids (as described in Materials and methods) with either 50 ng CD4-TLR4 (top) or 0.5 ng TLR3 (bottom) and 50–150 ng A46R or pcDNA3.1 (EV) as indicated. (bottom) Cells were stimulated with 25 μg/ml poly(I:C) 6 h before harvesting. Luciferase activity was measured after 24 h. (d) HEK-TLR3 cells were transfected with the indicated amounts (ng) of A46R 24 h before stimulation with 25 μg/ml poly(I:C), and 24 h after stimulation supernatants were harvested and assayed for RANTES by ELISA. (e and f) As in a and b, except Flag-SARM was transfected instead of Flag-TRIF.
A46R is expressed early during virus infection and contributes to virus virulence. (a) BSC-1 cells were mock infected (M) or infected with VV Western reserve (MOI = 5) in the absence or presence of 40 μg/ml cytosine β-D-arabinofuranoside (AraC). Cells were harvested at the indicated times (h) after infection, and lysates were subjected to SDS-PAGE and immunoblotting, using either anti-A46R (top) or anti-D8L (bottom) Ab. (b) A46R contributes to virus virulence. Groups of 15 female, 6-wk-old Balb/c mice were infected intranasally with 5 × 103 PFU of vWT-A46R, vΔA46R, or vA46R-REV. Each day, animals were weighed and the signs of illness were scored. Data are presented as the mean weight of each group of animals compared with the mean weight of the same group on day 0 (top graph), and the mean signs of illness score (bottom graph). Error bars are SEM. Asterisks represent days on which there was a statistically significant difference (P < 0.05; Student's t test) between the vWT-A46R and both control groups. (c) Number of cells recruited to the lungs of VV-infected mice. On days 2, 5, and 8 after infection, mice were killed, lungs were harvested, and cell suspensions were prepared. The total number of viable lung cells per animal was determined by Trypan blue exclusion. Data are means ± SEM.
A46R and A52R target different TLR3-mediated signaling pathways. (a and b) HEK 293 cells were transfected with 0.5 ng TLR3 and the indicated amounts (ng) of either A52R or A46R, together with the NF-κB (a) or IRF3 (b) reporter plasmids as described in Materials and methods. Cells were stimulated with 25 μg/ml poly(I:C) 6 h before harvesting where indicated. Luciferase activity was measured after 24 h. Relative stimulation is shown on the y axis.
287 Web of Science
297 Crossref
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF
Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor–mediated inflammatory responses
About JEM


text:
UC Berkeley Symposium Showcases Lessons Learned from the State of California's Excess Lands For Housing Initiative
Published On June 3, 2022
This year's James R. Boyce Affordable Housing Studio Symposium, held on May 4, 2022, spotlighted the State of California's ongoing efforts to redevelop state-owned excess lands for affordable housing. The full-day event at the Bancroft Hotel at UC Berkeley brought together developers, city officials, architects, state officials, and graduate students from a range of disciplinary backgrounds to reflect on the opportunities and challenges of the excess lands program, now in its third year of implementation.
The State's property holdings represent 2.9 million acres, an amount of land equivalent to the entirety of Los Angeles County. To date, 690 state properties have been identified as potentially suitable for affordable housing and 19 of them have been awarded to developers for purposes of redevelopment. These state-owned parcels represent a unique opportunity to deliver more housing as the state is not seeking to raise any revenue from sale or lease development and developers are able to bypass traditional project review processes that can otherwise stymie or stall worthwhile projects (state-owned lands are not necessarily subject to local zoning restrictions or development impact fees and the State may perform its own CEQA and building code review).
The symposium began with a panel discussion of the experiences of professionals in the field working on developments through the state-owned excess lands. The panel participants included three UC Berkeley Master of City Planning (MCP) alumni who had took the Boyce studio course in 2020 and are now supporting the excess lands program: Beatriz Sofia Stambuk-Torres (LeSar Development Consultants), Mona Al-Abadi (California HCD), and Michael Coulom (California HCD). The panel was moderated by Meea Kang, UC Berkeley Master of Architecture Alumna and Senior Vice President of Development for Related California.
Keynote Remarks
Sasha Wisotsky-Kergan, Deputy Secretary of Housing at the Business Consumer Services and Housing Agency, provided a keynote address. Wisotsky-Kergan described her work launching the program in 2019 and described the State's commitment to continuing to build on early successes. Lori O'Camb with the James R. Boyce Family Foundation also reflected on the benefits of the studio as it relates to growing the next generation of engaged professionals.
Student Presentations
Six student groups presented their proposals for affordable housing developments sited on two potential sites: one on an underutilized CalTrans site in Downtown Santa Cruz and the other on undeveloped Department of Corrections land adjoining a residential neighborhood in Folsom. Both sites had been identified as possible affordable housing opportunities but had not been subject by the State to due diligence to assess their viability for disposition. Student proposals were reviewed by juries comprising leading development, design, and planning professionals: Carol Galante with Terner Center for Housing Innovation, Lillian Lew-Hailer with Mercy Housing, Melanie Mintz with the City of El Cerrito, Yakuh Askew with Y.A. Studio, E.B. Min with Min Design, and Paulett Taggart with PTA.
Highlighted below are the winning proposals for each of the two sites.
Folsom Greens
Team Members: Ziyao Geng (MArch), Martine Kushner (MCP), Olivisa Lavecchia (MCP), Shiying Wang (MCP), and Hanyi Zhang (MArch)
Folsom Greens proposed to build a high-quality, high-opportunity, and mixed-income community that will be developed on state-owned land in the northeast of the City of Folsom. Folsom Greens is defined by strategies to 1) contain costs—thereby delivering more affordable housing, and more quickly, in a community that badly needs it—and 2) deliver services, amenities, and connections that result in a high quality of life for its residents. The proposal offered 202 affordable rental units serving households earning between 30 and 60 percent of Area Median Income (AMI) alongside 62 market-rate townhomes.
Riverstone Homes
Team Members: Elaine Forbush (MArch), Amelia Goldrup (MArch), John Maher (MBA), and Michelle Williams (MCP)
Riverstone Homes was proposed to create affordable housing in Santa Cruz that would serve as a foundation for community health, environmental health, and social connectivity. The team's primary focus was housing for mixed-income families with other supplementary services made possible through community partnerships. The housing would target mixed-income families earning between 30 and 80 percent of AMI, with an average AMI of 47 percent across all 229 units on the site. The first and largest phase of the project will provide housing to a range of household sizes at incomes ranging from 30 to 60 percent AMI, and the second and smaller phase will provide housing to a similar range of household sizes at incomes ranging from 30 to 80 percent AMI.
Blog post authored by Terner Center Managing Director and Adjunct Professor Ben Metcalf and Boyce Studio Teaching Assistant Robert Feign (Master of City Planning 2022). Co-instructors Daniel Simons and Cristina Rossi of David Baker+Partners Architects and Claire Parisa of California Housing Partnership joined Ben Metcalf in overseeing the semester-long studio.
Now Hiring! Research Leadership Opportunities
The Terner Center is hiring a Research Director and one to two Associate Research Directors to join our growing team.…
Terner Center Annual Report 2021-2022
We are very pleased to share our annual report for fiscal year 2021-2022. Find out more about the questions that…
Making the Case for Data Transparency and Clarifying the Goals of Recent Brief on Rising Rents
Letter from Ben Metcalf, Managing Director Our recent brief Rising Rents, Not Enough Data generated quite a few calls and…
UC Berkeley Team Takes Home 2nd Place at 2022 HUD Innovation in Affordable Housing Competition
Overview On April 13, four graduate-level student teams from across the country presented their development proposals in front of a…

redpajama_set_name: RedPajamaCommonCrawl


text:
You are here: Home / Hidradenitis suppurativa / Novel Agent Active in Dermatologic Conditions
Novel Agent Active in Dermatologic Conditions
March 5, 2019 /0 Comments/in Hidradenitis suppurativa /by Steve
WASHINGTON — A monoclonal antibody targeting interleukin-1 alpha (IL-1α) led to a 51% overall clinical improvement in patients with moderate or severe atopic dermatitis, a preliminary clinical trial showed.
All components of the composite score improved significantly with the higher dose of bermekimab versus the lower dose, which improved disease status by 17% from baseline. The magnitude of clinical improvement correlated with the mean serum level of bermekimab.
The drug was well tolerated, as only two grade III adverse events occurred in 38 patients, both treated with the lower dose of bermekimab, Eric Simpson, MD, of Oregon Health & Science University in Portland, reported here at the American Academy of Dermatology meeting.
"Targeting interleukin-1 alpha with this drug in adults with moderate to severe atopic dermatitis really showed a nice early signal for improved signs and symptoms," Simpson said. "We observed rapid reduction in itch and pain. Maybe this has something to do with the sensory nerve potentiation. Based on these results, the bermekimab clinical program in atopic dermatitis will advance to later-stage studies."
Results of a second small clinical trial of bermekimab showed significant improvement in moderate-severe hidradenitis suppurativa after 12 weeks of treatment. The drug proved active in patients with and without prior exposure to a tumor necrosis factor (TNF) inhibitor, as reported by Alice Gottlieb, MD, PhD, of Tufts University in Boston.
Both studies showed significant improvement in pain.
IL-1 occurs in abundance in keratinocytes and the IL-1 receptor is found on virtually all cells, said Simpson. Activated leukocytes produce IL-1α, which induces matrix metalloproteinase, potentiates pain perception, drives neoangiogenesis, and induces inflammatory cell infiltrates in skin.
Bermekimab was derived from a natural human humoral response to IL-1α. The monoclonal antibody binds and neutralizes IL-1α, does not bind IL-1β, and binds all forms of IL-1α (full, processed, membrane-bound, and soluble).
Bermekimab has been evaluated clinically in a total of 130 patients representing five types of dermatologic diseases: atopic dermatitis, hidradenitis, acne, psoriasis, and pyoderma gangrenosum. The agent demonstrated good activity in all the conditions, said Simpson, and a new subcutaneous formulation achieves >90% bioavailability.
Investigators in a pilot trial of bermekimab enrolled patients with moderate-severe atopic dermatitis: body surface area (BSA) ≥10%, investigator global assessment (IGA) ≥3, and eczema area and severity index (EASI) ≥16. All the patients had an inadequate response or intolerance to topical corticosteroids.
Ten patients received four weekly injections of 200 mg of bermekimab, and the remaining 28 patients in the trial received seven weekly injections of 400 mg. The primary endpoint was safety and tolerability. Secondary endpoints included change from baseline in EASI, IGA, the Scoring Atopic Dermatitis (SCORAD) calculator, the Patient-Oriented Eczema Measure (POEM), IGA, pruritus, and pain.
One patient in the 200-mg group and eight in the 400-mg group discontinued before the end of the study, one because of lack of response, four for adverse events, and the rest for miscellaneous reasons. The patient data were included in the analysis as last observation carried forward (LOCF), said Simpson.
The 200-mg dose led to a mean serum trough level of 13 μg/mL versus 44 μg/mL for the 400-mg dose, a threefold difference. That tracked closely with the 3.4-fold difference in clinical improvement (defined by EASI, SCORAD, IGA, and global individual signs score or GISS), and bioavailability was 94% with the 400-mg dose and 62% with the 200-mg dose.
Patients in the 400-mg group had almost an 80% improvement from baseline in EASI score versus 20% with the lower dose (P<0.001), and the proportion of patients achieving 75% improvement in EASI were 70% versus 40%. The change in SCORAD averaged 20% with the lower dose of bermekimab and almost 70% with the higher dose (P<0.0001). The reduction in GISS averaged 10% with 200 mg and almost 60% with 400 mg (P<0.0001).
IGA improvement, limited to the 400-mg group, showed 30% improvement at 4 weeks and more than 40% at 7 weeks (P<0.001 for both). A fourth of patients achieved an IGA of 0 or 1 plus at least a 2-point improvement from baseline to week 7.
Itch and worst itch declined by 40-50% with 200 mg of bermekimab versus about 70% with 400 mg (P<0.0001). The mean reduction in pain score in the 400-mg group exceeded 80% by week 7.
Gottlieb reported findings of 42 patients with moderate to severe hidradenitis suppurativa enrolled in a phase II evaluation of the 400-mg dose of bermekimab. The study group consisted of 24 patients who had not responded to a TNF inhibitor and 18 who had no prior anti-TNF therapy. Baseline hidradenitis suppurativa clinical response (HiSCR) scores averaged 14.1 in the anti-TNF failure group and 6.3 in the non-TNF inhibitor group.
Eight patients, all in the anti-TNF failure subgroup, discontinued treatment before 12 weeks — two because of adverse events (injection-site redness, worsening hypertension). Their data were analyzed by LOCF imputation.
By week 12, 60% of patients in both subgroups met criteria for HiSCR positivity. Improvement in Physicians Global Assessment increased from 10% at week 2 to more than 20% at week 12 in the anti-TNF failure group (P=0.002), and from about 15% to more than 50% in the patients with no prior anti-TNF therapy (P<0.0001). Patients' self-rating of disease status improved by 40% and 50% at week 12 in the patients with and without prior anti-TNF treatment (P<0.0001). Quality-of-life scores improved by 40% and 60%, respectively (P<0.0001).
All but one adverse event were grade 1-2. Two serious adverse events occurred during the study, both considered unrelated to treatment medication (one fall and one case of grade 3 hidradenitis suppurativa-related pain).
"Weekly subcutaneous bermekimab improved all disease measures with excellent safety," said Gottlieb. "These findings support progress to phase III. Targeting interleukin-1 alpha may represent a novel effective treatment for moderate to severe hidradenitis suppurativa."
Both studies were supported by XBiotech.
Simpson disclosed relationships with AbbVie, Dermira, Eli Lilly, LEO Pharma, Pfizer, Pierre Fabre, Regeneron, and XBiotech.
Gottlieb disclosed relationships with AbbVie, Avotres, Celgene, Dermira, Incyte, Janssen, LEO Pharma, Lilly, Novartis, Sun Pharmaceutical, and XBiotech.
https://i2.wp.com/higenix.com/wp-content/uploads/2019/03/78350.jpg?ssl=1 Steve https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png Steve2019-03-05 02:30:072019-03-05 02:30:07Novel Agent Active in Dermatologic Conditions
HS – News & Articles
The Hidradenitis Suppurativa Treatment Market to strike balance between existing and upcoming technology in the next 10 years – The Pinstripe Empire January 15, 2021
ChemoCentryx: Great Drug, Good Prospects, Uncomfortable Stock Price January 15, 2021
Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company Nasdaq:KYMR January 13, 2021
Global Hidradenitis Suppurativa Treatment Market 2019 Biggest Innovation To Boost Global Growth||TARGET PharmaSolutions, Inc., Eisai Co., Ltd, Abbott, ALLERGAN, AstraZeneca, GlaxoSmithKline plc January 13, 2021
Global Hidradenitis Suppurativa Therapeutics Market 2020 Research Study with Trends and Opportunities to 2025 – Impact of COVID-19 – The Courier January 12, 2021
© Copyright - HIGENIX - Hidradenitis Suppurativa Natural Treatment - All Rights Reserved.
Global Hidradenitis Suppurativa Treatment Market Growth Opportunities, Analysis... SBCC student musician hopes to be the next American Idol – The Channels


text:
The Shrew's Proposal
Posted by Sashoya Dougan in English 3 · Pahomov · B Band on Monday, April 30, 2018 at 3:53 pm
The two pieces I decided to cross-analyze were Shakespeare's Taming of the Shrew and Anna Fletchers The Proposal. In Shakespeare's Taming of the Shrew he shows the progression of a forced love, the two main characters Petruchio and Katherine despise each other and go through with a marriage based on outside issues pushing them to go through with it. In Anna Fletchers The Proposal we too are presented with two characters, Margaret and Andrew, that are forced into an engagement and are relying on the promises they gave one another other in order to continue with this fake engagement.
In Shakespeare's play, our two main characters are pushed into their marriage by outside forces, Petruchio wants money and Katherine craves her father's love and acceptance. The fastest way for these characters to obtain their desires is through a sham marriage. In The Proposal their engagement is forced by the female lead, Margaret, she needed our other main character, Andrew to keep the lie, that they are engaged, going in order to keep her job. The only thing that kept Andrew in the deal was a raise and a publishing deal that he made Margaret give to him in exchange for keeping the lie. In both pieces, it is argued that because of the hardships that both parties face while being forced to "love" each other, forced loves are the strongest loves in the end.
The first scene I chose to include from Shakespeare's piece was one of Katherine and Petruchio's first encounters.
Katherine: If I be waspish, best beware my sting.
Petruchio: My remedy is then to pluck it out.
Katherine: Ay, if the fool could find where it lies.
Petruchio: Who knows not where a wasp does wear his sting? In his tail.
Katherine: In his tongue.
Petruchio: Whose tongue?
Katherine: Yours, if you talk of tales, and so farewell.
Petruchio: What, with my tongue in your tail?
(II.i.207–214)
Towards the beginning of Taming of the Shrew, Kate and Petruchio's very first interactions were noticeably passive and slightly flirty. Petruchio is the one to initiate the flirting and eventually declares it his mission to have Kates hand in marriage. There was no sign of love, in the beginning, both characters could barely stand each other but their dynamic was already very flirty considering the circumstances.
This same setup and dynamic is seen with Margaret and Andrew towards the middle of The Proposal.
Margaret Tate: If you touch my ass one more time I will cut your balls off in your sleep, okay?
Andrew Paxton: Yup
Margaret Tate: Alrighty then
Margaret and Andrew had been staying in Andrews' parent's house for his grandmother's birthday. His family was under the impression that they were together so when the "couple" had been noticeably distant Andrew takes it upon himself to bring Margaret in for a hug followed by a little pat on her bottom to assure his mother and grandmother, that had been watching their little conversation from the window, that they were still a happy couple.
Since Margaret was Andrew's boss and he disliked her immensely at times he took this as a great opportunity to be in charge, he knew she couldn't openly oppose him in front of his parents or their plan would fail. Even though that was the case Margaret still established her place in their power dynamic but threatening him the way she did and giving him a loving little slap on the side of his face. Watching their relationship shit throughout the movie definitely proved that what they had to go through changed them for the better and brought them together.
In the following scene, Petruchio and Katherine are preparing themselves for company and need to put on their best married couple attitudes. Petruchio makes a point that the moon is shining brightly at the moment. Katherine quite confused points out the fact that it is indeed morning and it is the sun that is shining so bright.
PETRUCHIO: Come on, I' God's name, once more toward our father's.
Good Lord, how bright and goodly shines the moon!
KATHERINE: The moon? The sun! It is not moonlight now.
PETRUCHIO: I say it is the moon that shines so bright.
KATHERINE: I know it is the sun that shines so bright.
HORTENSIO: (to KATHERINE) Say as he says, or we shall never go.
KATHERINE: Forward, I pray, since we have come so far, And be it moon, or sun, or what you please. An if you please to call it a rush candle, Henceforth I vow it shall be so for me.
PETRUCHIO: I say it is the moon.
KATHERINE: I know it is the moon.
PETRUCHIO: Nay, then you lie. It is the blessèd sun
KATHERINE: Then God be blessed, it is the blessèd sun. But sun it is not, when you say it is not, And the moon changes even as your mind. What you will have it named, even that it is, And so it shall be so for Katherine.
(V.ii.140–183)
At this point in the play, Katherine and Petruchio know enough about each other to predict one another's behavior and recognize their traits. Katherine who is normally up for a fight when it comes to Petruchio's actions and profound comments does something out f character.
When the time for Katherine to fight back in her and Petruchio's argument another character named Hortensio points something out. He states that they would never leave if she didn't just agree with him, and it clicks for her. Katherine finally recognizes the pattern between the two of them and decides to do something out of character, she gives in. Even though Katherine has never been one to give up a fight she realizes that if she is to keep up this so-called loved in their sham of a marriage Petruchio has to be happy, which also means he has to be right.
A similar sacrifice is shown in a popular scene of The Proposal. Margaret and Andrew have just left their place of work after lying about their engagement in order to keep Margaret's job. Margaret explains the plan and how she wants everything to happen and Andrew reluctantly agrees. Andrew with a serious look on his face asks for his proposal and Margaret baffled declines seeing the action as demeaning, Andrew begins to call off the deal but Margaret stops him. Knowing that Andrew would leave if she didn't do this action in the middle of the street to please his ego she gets down and proposes.
Andrew Paxton: We'll tell my family about our engagement when I want and how I want. Now, ask me nicely.
Margaret Tate: Ask you nicely what?
Andrew Paxton: Ask me nicely to marry you... Margaret.
Margaret Tate: What does that mean?
Andrew Paxton: You heard me. On your knee.
Margaret Tate: [she kneels] Fine. Does this work for you?
Andrew Paxton: Oh, I like this. Yeah.
Margaret Tate: Here you go. Will you marry me?
Andrew Paxton: No. Say it like you mean it.
Margaret Tate: Andrew.
Andrew Paxton: Yes, Margaret.
Margaret Tate: Sweet Andrew.
Andrew Paxton: I'm listening.
Margaret Tate: Would you please, with cherries on top, marry me?
Andrew Paxton: Ok. I don't appreciate the sarcasm, but I'll do it. See you at the airport tomorrow.
Margaret being the natural boss that she is has to take a step back and get over herself to save her career. This is the first dynamic change in this couple that eventually brings the two closer. By putting her guard down and allowing him to be "in charge" in this situation she is building the strength and equality in their relationship.
In my last two comparisons, I chose the two strongest character change scenes.
My mind hath been as big as one of yours,
My heart as great, my reason haply more,
To bandy word for word and frown for frown;
But now I see our lances are but straws,
Our strength as weak, our weakness past compare,
That seeming to be most which we indeed least are.
Then vail your stomachs, for it is no boot,
And place your hands below your husband's foot,
In token of which duty, if he please,
My hand is ready, may it do him ease.
Throughout the play we have come to know Katherine as a strong-willed, stubborn independent woman, we have never known her to be submissive. In this scene, Katherine takes it upon herself to address the wives of the other husbands present in the room. After her little speech, she goes over and gives Petruchio a kiss, with everything that went on between the two something must have brought them together. The struggles that they both faced while in the relationship has changed them so much that they have formed their nemesis into a real relationship.
The same thing happens with Andrew in The Proposal but his approach is a little more aggressive. Margaret leaves Andrew at the altar right when everything is about to be put in place and goes back to her job to collect her things and leave… forever. Andrew, realizing that he had fallen in love with her rushes to their place of work and confesses to her, in front of everyone.
Andrew Paxton: Three days ago, I loathed you. I used to dream about you getting hit by a cab. Then we had our little adventure up in Alaska and things started to change. Things changed when we kissed. And when you told me about your tattoo. Even when you checked me out when we were naked. But I didn't realize any of this until I was standing alone... in a barn... wifeless. Now, you could imagine my disappointment when it suddenly dawned on me that the woman I love is about to be kicked out of the country. So Margaret, marry me because I'd like to date you.
In the beginning, Andrew kept his tail between his legs around Margaret, she was very intimidating and he didn't want much to do with her. He later found that the only way to get his point across and actually keep the woman that he loved he had to abandon his normal coward like behavior and stand up to her.
In both The Proposal and Taming of the Shrew, we see two couples that can't stand each other but need each other to succeed in life. In order for their relationship dynamics to work, they have to sacrifice certain strong traits that they are known for. By going through hardships while simultaneously getting rid of parts of themselves they grew closer. The love that these characters had for each other may not have been traditional but it was strong, everything they went through helped them form the love they have for each other at the end of their story.


text:
IELTS Coaching in Kolkata
3709 Ratings | Read Reviews
FITA Academy IELTS Coaching in Kolkata is an integrated professional course dedicated to equipping the trainees with the professional skills and the linguistic knowledge of the english language required to achieve high scores in the IELTS (International English Language Testing System) test, one of the most popular and commonly used tests of the english language that has been designed to test the proficiency of non-native speakers in the english language in all forms, i.e., listening, reading, writing and speaking in english. Our IELTS Training in Kolkata is developed and delivered by expert professionals who have had rich and diverse work experience in the english language and IELTS test training sector for at least 10+ years with special focus and emphasis on training students in qualifying tests of the english language like IELTS and TOEFL and have successfully trained hundreds of learners to obtain high band scores in the IELTS test using a mix of unique and individually curated test preparation strategies and resources.
Course Highlights & Why IELTS Coaching in Kolkata at FITA Academy?
FITA Academy IELTS Training in Kolkata gives a broad view and detailed insights into the IELTS (International English Language Testing System) test structure and formats and the best test preparation strategies for the IELTS test
Our IELTS Coaching in Kolkata has a training curriculum designed and developed as per the latest changes and developments in the english language and IELTS test training sector as well as the best-tested preparation methods
Our IELTS Course in Kolkata is developed and delivered by expert professionals who have had rich and diverse work experience in the english language and IELTS test training sector for at least 10+ years with a focus on IELTS
Our IELTS Coaching in Kolkata has a training schedule designed with the utmost flexibility to cater to the needs and requirements of our diverse group of trainees, and we provide instructor based online training apart from classes
FITA Academy is one of the finest IELTS Course in Kolkata and has a course module developed according to the perfect balance of theoretical and practical sessions
To equip the trainees with the linguistic understanding and the competitive skills needed to achieve a high score in the IELTS (international english language testing system) test using a broad and extensive knowledge of english
To ensure that the learners have the maximum possible industry exposure into the english language and the IELTS test training sector to practice and perfect their skills and develop a test preparation strategy best suited to them
To train the students in the most intricate and strategic application of the different resources of the english language including its grammar rules, speaking styles, common words and phrases, and semantic differences
To give a broad and overall view of the IELTS test and its different modules and test structures, with an in-depth knowledge of the various types of questions and expected responses in all the sections like writing and speaking
To equip the trainees with an in-depth and extensive understanding of the IELTS test structure and the various test preparation strategies and helping them achieve high scores in the test while keeping them aware of advances
Get trained by Industry Experts via Classroom Training at any of the FITA Academy branches near you
Why Wait? Jump Start your Career by taking IELTS Coaching in Kolkata!
Travelling is a Constraint? Jump Start your Career by taking the IELTS Online Coaching!
FITA Academy IELTS Training in Kolkata is developed and delivered by expert professionals who have had a rich and diverse work experience in the english language and IELTS training sector for at least 10+ years
Our IELTS test mentors have extensively worked in training for tests of english language like IELTS and TOEFL and have successfully trained hundreds of students in achieving high scores in the IELTS test
Our IELTS test trainers use a wide range of training methods and give extensive and exclusive insights into the different test preparation strategies, preparing the trainees in all the aspects of the english language
Our IELTS test mentors will skillfully guide you through the various parts of the IELTS test strucutre, linguistic knowledge and understanding of the english language and its grammar rules and semantic intricacies
Our IELTS test trainers will encourage and motivate you to undertake more and more mock tests and practical assignments to improve your skills and performance and increase your confidence and give guidance and support
IELTS Certification Training in Kolkata
About IELTS Certification Training in Kolkata at FITA Academy
Job Opportunities After Completing IELTS Coaching in Kolkata
The IELTS (International English Language Testing System) is one of the most common and popularly used tests for the english language by most academic and non-academic institutions along with professional associations and organizations, and is the gold standard for testing a person's proficiency in the english language in all the different aspects, i.e., reading, listening, speaking and writing, and is the basis for admission in higher studies and professional or non-academic work-based training and skill development programs for institutes and organizations across the world, especially in the USA, UK, Canada, Australia, and New Zealand amongst others. With increasing globalization and the ongoing trends of student exchange programs and employee exchange programs, traveling abroad to English speaking countries has become very common, especially with the presence of better educational and employment opportunities and the overall better standard of living in these countries, leading to enhanced performance, skill development, greater access to global resources and an overall improved lifestyle and academic and professional productivity.
The knowledge of english language and overall proficiency in the language is imperative for a better adaptation into the new academic and work culture in these countries, and helps emigrants better understand the cultural differences, aids in improved interpersonal communication and active participation in communities, and gives a boost to overall confidence of the emigrants, helping their performance and adjustment to the new lifestyle. The IELTS test is a necessity for a great number of academic institutions and professional organizations across the world, that generally demand a band score of not less than 6 to 8 to even be considered for selection or shortlisting of the application, and is one of the few english language tests that provide find acceptance and recognition across the world, and is succeeded only by TOEFL (test of english as a foreign language). To obtain good overall and individual scores in the IELTS test, a candidate needs to not only be fluent in the english language but also an expert and an active user of english in interpersonal communication in the personal and professional domains, while also being able to understand complex and intricate sentence formations and their intended meanings. Along with a stronghold on the grammar rules and laws, the candidate is expected to have a good overall grasp in the fluency of thoughts in the english language for articulate expressions, an expansive and working vocabulary, and confidence in interactions in the english language with correct usage of common words and phrases.
FITA Academy IELTS Coaching in Kolkata has been developed and curated to equip the trainees with the professional skills and the linguistic knowledge of the english language to help them qualify and ace the IELTS (International English Language Testing System) test to be accepted in various academic institutions and professional associations and organizations across the globe, especially in native english speaking countries. Our IELTS Course in Kolkata is developed and delivered by expert professionals who have had rich and diverse work experience in the english language training and IELTS test preparation sector for at least 10+ years, having trained thousands of students in achieving high band scores in tests like IELTS and TOEFL. Our IELTS Training in Kolkata is aimed at giving the trainees the maximum exposure and practice through assignments and workshops to ensure that they have the semantic knowledge and linguistic understanding of the english language to not only obtain high scores in the test but also ensure that they can confidently and fluently interact in and understand the language.
Anupriya Dutta
FITA Academy IELTS course in Kolkata helped me develop confidence in my english communications and gave me the practical exposure I needed to excel in the language, along with helping me develop a strategy to crack the IELTS test and get a band score of more than 7 to be accepted in my professional organization.
Manya Dixit
FITA Academy is one of the finest IELTS coaching centers in Kolkata and gives equal and adequate emphasis on all the different aspects of the IELTS (International English Language Testing System) test, i.e., on the listening, reading, writing, and speaking sections, and creates a wholesome approach to the test and learning the english language.
Shashwat Ghosh
I attended FITA Academy IELTS training in Kolkata with little understanding of the english language, and the course helped me develop confidence in speaking english, especially in day-to-day interpersonal communication along with giving me a robust and personal plan for the test preparation. I would highly recommend this course.
Vishwajeet Sengupta
I think FITA Academy is one of the best choices for an IELTS institute in Kolkata and has a unique and tested approach for the test preparation for IELTS that focuses on the semantic knowledge of the english language and a robust understanding of its linguistic styles and structures. I am highly grateful to this course and my mentors.
Manasvi Desai
I attended FITA Academy IELTS coaching in Kolkata with prior knowledge of the english language, to better train myself in the preparation for the IELTS test so that I could qualify the requisite test score in my second attempt after falling short on the first attempt. The training module and strategy for IELTS are excellent and it helped me develop a more nuanced understanding of the entire process.
IELTS Coaching in Kolkata Frequently Asked Question (FAQ)
What does the course structure comprise of?
FITA Academy IELTS training in Kolkata has been developed and curated to equip the trainees with the professional skills and the linguistic understanding of the english language and the latest and most effective test preparation strategies so that they have the skills, confidence, and competence to ace in the IELTS (International English Language Testing System) test and obtain high band scores to be accepted in various academic institutions and professional associations.
What is the selection criteria for my trainers?
The criteria are to have a minimum of 10+ years of expertise in successfully training students and professionals in qualifying for the IELTS test, and is further supplemented by interviews and professional assessments.
How can I learn more about FITA Academy IELTS training in Kolkata?
Kindly call us or submit the enquiry form, or reach us through the live chat IVR service.
The International English Language Testing Systems (IELTS), as the name suggests, is one of the most popular and commonly used tests of the English language and the skills of the examinee in reading, writing, understanding and speaking fluently in the english language, meant for non native speakers, and is one of the major tests in the english language across the world for being admitted into academic and educational institutions, professional associations and organizations, and to obtain visas for visiting several english speaking countries throughout the globe, including the list of certifications needed for a range of institutes and professional affiliations. The IELTS test is generally accepted within twenty-four months from the date of issue and has no minimum score requirement, rather it ranks all the test takes into nine different bands, each reflective of the level of skills and proficiency of the examinees in speaking, writing, reading and overall communicating in the English language, while it also has the zero band for people who did not appear for the test; and generally most institutions, academic or professional accepts a score within six to eight bands, while the ninth band is for the expert user who has fluent and perfect command over the language and the lowest band is representative of the non-user.
The type of test depends on the academic, professional, or personal requirements of the test taker and the test is available in two basic formats; the IELTS Academic Module (meant for students willing to attend university or other institutions for higher education, and for professionals and professional associations for doctors, engineers, actuarial scientists, etc) and the IELTS General Training Module (meant for those people who wish to undergo non-academic or non-technical training, or for immigration assistance), along with the IELTS Life Skills (meant for test-takers who have to show their proficiency in the English language to the Common European Framework of Reference of Languages, CEFR, and assists in obtaining UK citizenship). The IELTS (International English Language Testing System) test consists of four major sections: listening, reading, writing, speaking, of which the first three are conducted together and the speaking test may be given on the same date or on a later date. FITA Academy IELTS Coaching in Kolkata is aimed at combining and integrating the different aspects, linguistic styles, common words, and phrases of the english language and the major strategies, plans, and practices used in the test preparation for the IELTS (International English Language Testing System) test in the different formats, i.e., the IELTS Academic Module, the IELTS General Training Module, and the IELTS Life Skills, along with individual and specifically targeted preparation strategies and plans, into a single comprehensive and cohesive training module to help students achieve their respective goals and obtain high band scores in the test, as well as gain expertise in the english language and fluently communicate in both professional and interpersonal settings. As one of the best coaching centers in Kolkata, we at FITA Academy are dedicated to providing our learners with the maximum possible industry exposure into the english language training and IELTS test preparation sector to practice and perfect their skills and ensure that they have strategic knowledge and the interpersonal communication skills in the english language to achieve high band scores in the test and develop excellent overall reading, writing, listening and speaking skills in the english language to help the learners in their professional journeys. FITA Academy IELTS Course in Kolkata is based on a course module designed in view of the latest and the most effective test preparation strategies for the IELTS test across the world and in different parts of the country, along with the latest developments in the test pattern and structure to ensure that our IELTS trainees have the linguistic and the interpersonal communication skills to ace in all the sections of the test.
FITA Academy IELTS Training in Kolkata has been developed and curated to equip the trainees with the professional skills and the linguistic understanding of the english language and the latest and most effective test preparation strategies so that they have the skills, confidence and the competence to ace in the IELTS (International English Language Testing System) test and obtain high band scores to be accepted in various academic institutions and professional associations. As the finest IELTS Coaching in Kolkata, we at FITA Academy are focused on developing a course structure that stresses both the theoretical aspects of the IELTS test preparation strategies in terms of an in-depth understanding of the english language and its grammar rules, the styles of speaking and the correct use of words and phrases with the practical aspects of the IELTS test preparation strategy in terms of making an elaborate and individually curated strategy as per the needs and requirements of the candidate, using the wide range of available resources and taking mock tests to help track progress and identify areas of strengths and weaknesses. FITA Academy IELTS Course in Kolkata emphasizes providing the professional skills and the linguistic understanding of the english language along with rigorous training for the IELTS test preparation to ensure that our trainees have the competitive edge and competence to not only obtain high scores but also effectively use the english language in their day to day professional and personal communication.
FITA Academy IELTS Training in Kolkata is developed and delivered by expert professionals who have had a rich and diverse work experience in the english language training and IELTS test preparation sector for at least 10+ years, with special focus and emphasis on creating test preparation strategies for tests of the english language like IELTS and TOEFL and have successfully trained hundreds of students in obtaining high scores in the IELTS test. Our IELTS test trainers help our learners become familiar and comfortable with the IELTS test structure and the format according to their requirements and ensure that they have the skills and the confidence to successfully qualify the test with high scores. Our IELTS test mentors emphasize providing practical assignments and training with individually curated test preparation strategies.
IELTS Online Coaching
IELTS Training in Bangalore
IELTS Coaching in Coimbatore
IELTS Coaching in Madurai
IELTS Coaching in Hyderabad
Best IELTS Coaching in Gurgaon
IELTS Training In Pune
IELTS Coaching in Mumbai
IELTS Coaching Centers in Kochi
IELTS Classes in Ahmedabad
IELTS Coaching Centers in Trivandrum
Digital Marketing Course in Kolkata Software Testing Courses in Kolkata Selenium Training in Kolkata Android Training in Kolkata Swift Developer Course in Kolkata RPA Course in Kolkata AWS Training in Kolkata DevOps Training in Kolkata Cyber Security Course in Kolkata Ethical Hacking Course in Kolkata Java Training in Kolkata Full Stack Developer Course in Kolkata Python Training in Kolkata PHP Training in Kolkata Dot Net Course in Kolkata AngularJS Training in Kolkata
Data Science Course in Kolkata Artificial Intelligence Course in Kolkata Graphic Design Courses in Kolkata Spoken English Course in Kolkata German Language Course in Kolkata IELTS Coaching in Kolkata Hacking Course Online RPA Online Course AngularJS Online Training PHP Training Online German Language course Online Online Graphic Design course Online Speaking English Course IELTS Online Training AI Online course Learn Java Online Selenium Training Online Learn Python Online Digital Marketing Online Course Android Course Online Dot Net Online Training Software Testing Course Online Best Online Data Science Courses DevOps Online Course AWS Online Course Learn Swift Online
Alipore, Carmac Street, JL Nehru Road, Kalighat, Kasba, Kona Expressway, New town, Park Street, Rajarhat, Salt Lake City, Sarat Bose Road, Science City and Strand Road.